[SCHEDULE 13G] AnaptysBio, Inc. SEC Filing

Rhea-AI Filing Summary

The Vanguard Group has filed a Schedule 13G disclosing beneficial ownership of 3,688,628 Daktronics (DAKT) common shares, representing 7.51 % of the outstanding class as of 30 Jun 2025.

According to the filing, Vanguard holds no sole voting power and only 37,557 shares under shared voting power, underscoring its passive stance. In contrast, it possesses substantial dispositive authority: 3,612,884 shares sole dispositive and 75,744 shares shared dispositive power. The firm categorises itself as an investment adviser under Rule 13d-1(b) and certifies that the securities were acquired in the ordinary course, without intent to influence control.

Crossing the 5 % threshold elevates Vanguard to a significant institutional holder, potentially broadening DAKT’s shareholder base and enhancing stock liquidity, albeit with limited immediate governance impact due to the minimal voting rights exercised.

Positive

• Vanguard Group now owns 7.51 % of DAKT (3.69 M shares), adding a respected institutional investor to the shareholder roster.

Negative

• None.

Insights

Securities Analyst

TL;DR: Vanguard’s 7.5 % passive stake boosts institutional ownership, improving liquidity and visibility without altering control.

The stake size is material for a small-cap issuer like DAKT, signalling confidence from a leading asset manager. While Vanguard wields negligible voting power, its dispositional authority over 3.6 M shares increases market depth and may reduce float volatility. Passive 13G status implies no activist agenda, limiting near-term strategic influence. Overall impact is favourable for investors seeking stronger institutional sponsorship.

Corporate Governance Expert

TL;DR: Passive filing limits governance influence; disclosure mainly satisfies regulatory transparency.

Because Vanguard filed on Form 13G rather than 13D, it affirms no intent to influence board composition or corporate actions. With virtually zero sole voting power, the group’s ability to sway shareholder resolutions is minimal. Nonetheless, management should note that large passive holders increasingly support ESG proposals, so alignment with Vanguard’s policies can shape future proxy outcomes even without formal activism.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AnaptysBio Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

032724106

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 032724106

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 21,564.00
7	Sole Dispositive Power 1,502,076.00
8	Shared Dispositive Power 35,474.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,537,550.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.23 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AnaptysBio Inc
(b)	Address of issuer's principal executive offices: 10421 Pacific Center Court, Suite 200, San Diego, CA, 92121
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd., Malvern, PA 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 032724106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1537550
(b)	Percent of class: 5.23 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 21564
	(iii) Sole power to dispose or to direct the disposition of: 1502076
	(iv) Shared power to dispose or to direct the disposition of: 35474
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	07/29/2025

FAQ

Why did The Vanguard Group file a Schedule 13G on DAKT?

The filing discloses that Vanguard passively accumulated 7.51 % of Daktronics common stock, exceeding the 5 % threshold that triggers reporting.

How many Daktronics shares does Vanguard control?

Vanguard reports 3,688,628 beneficially owned shares, with dispositive power over 3,688,628 and voting power on only 37,557 shares.

Is Vanguard’s position activist or passive?

The Schedule 13G designation and certification confirm a passive investment with no intent to influence control.

What percentage of Daktronics’ outstanding shares does Vanguard hold?

Vanguard holds 7.51 % of Daktronics’ outstanding common stock as of 30 Jun 2025.

Does Vanguard have significant voting power in Daktronics?

No. Vanguard lists 0 sole voting power and 37,557 shared voting power, limiting its influence on shareholder votes.